Drug Profile
EO 1428
Latest Information Update: 25 Jul 2001
Price :
$50
*
At a glance
- Originator LEO Pharma
- Class Anti-inflammatories
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Inflammation
Most Recent Events
- 25 Jul 2001 Discontinued-Preclinical for Inflammation (Topical)
- 21 Jul 1999 New profile
- 21 Jul 1999 Preclinical development for Inflammation (Topical)